Australia markets closed

ANI Pharmaceuticals, Inc. (ANIP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
66.65-0.46 (-0.69%)
As of 11:16AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close67.11
Open67.87
Bid66.45 x 200
Ask66.96 x 100
Day's range66.65 - 67.87
52-week range37.87 - 70.81
Volume15,217
Avg. volume145,387
Market cap1.398B
Beta (5Y monthly)0.80
PE ratio (TTM)78.41
EPS (TTM)0.85
Earnings date10 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est79.80
  • Zacks

    Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?

    Here is how Amarin (AMRN) and ANI Pharmaceuticals (ANIP) have performed compared to their sector so far this year.

  • Zacks

    Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y

    Moderna (MRNA) beats expectations for both earnings and sales. Management reiterates guidance to record around $4 billion from product sales in 2024.

  • GlobeNewswire

    ANI Pharmaceuticals to Participate at Two Upcoming Healthcare Conferences

    BAUDETTE, Minn., May 01, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will participate at two upcoming healthcare conferences in New York City as follows: Capital One 1st Annual Biotech/Biopharma Disruptors Event Date:Tuesday, May 14, 2024 Time:12:15pm ET To schedule a 1x1 meeting with management, please contact kristen.patrick@capitalone.com H.C. Wa